HomeNRXP • NASDAQ
add
NRX Pharmaceuticals Inc
Previous close
$1.23
Day range
$1.21 - $1.27
Year range
$1.10 - $7.33
Market cap
13.54M USD
Avg Volume
163.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.02M | -47.97% |
Net income | -1.62M | 73.23% |
Net profit margin | — | — |
Earnings per share | -0.15 | 78.57% |
EBITDA | -3.02M | 47.98% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.65M | -81.51% |
Total assets | 4.46M | -65.96% |
Total liabilities | 23.28M | 20.47% |
Total equity | -18.82M | — |
Shares outstanding | 12.09M | — |
Price to book | -0.75 | — |
Return on assets | -155.36% | — |
Return on capital | 64.22% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.62M | 73.23% |
Cash from operations | -2.31M | 49.47% |
Cash from investing | — | — |
Cash from financing | 2.05M | 236.84% |
Net change in cash | -252.00K | 95.85% |
Free cash flow | -119.75K | 96.41% |
About
Founded
2015
Headquarters
Website
Employees
2
